Thanks for the share!

I have yet to read the full paper but that abstract and a cursory purview is not promising of the validity of the conclusions the paper is implying regarding Covid-19 vaccinations; there appears to be no meaty analysis of:

• how the populations studied aren’t reflecting increasingly diminished access to healthcare,
• that confirming a vaccination is so much easier than a recent or historical covid-19 infection
• there are no known pathognomic symptoms of COVID-19 other than maybe anosmia that distinguish from other viral illnesses, and there is no method of diagnosing a subclinical covid-19 infection noted in each of those patients that got a vaccine and then a subsequent cancer
• and all of the above is on the background of known effects of COVID-19 pathophysiology on the immune system, especially T-cell mediated pathways

I was interested initially because of potential analysis on mRNA vaccines. The most curious thing for me on the paper is potential site injection cancers and I have to read it in more detail but superificially the way they seem to explain it appears to be a bit shoddily done and therefore gets me questioning its validity.